Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease
Authors:
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 40 (2) , 329-343
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytesBlood, 2012
- Aspirin-exacerbated respiratory disease: Burden of diseaseAllergy and Asthma Proceedings, 2012
- Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: A double-blinded, randomized controlled trialThe Laryngoscope, 2011
- The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2005
- Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2003
- The natural history and clinical characteristics of aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2002
- Cromolyn Sodium Prevents Bronchoconstriction and Urinary LTE4 Excretion in Aspirin-Induced AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Long-term effects of aspirin desensitization—Treatment for aspirin-sensitive rhinosinusitis-asthmaJournal of Allergy and Clinical Immunology, 1990
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionNew England Journal of Medicine, 1985
- Aspirin-sensitive rhinosinusitis asthma: A double-blind crossover study of treatment with aspirinJournal of Allergy and Clinical Immunology, 1984